Interestingly, the fact that neuro-ophthalmic events are often tied to lung cancer patients on anti–PD-1 (per the review data) suggests some tumor antigen might prime an attack on neuromuscular components (e.g. muscle acetylcholine receptors in myasthenia). This evidence concerns the gene PDCD1 and lung carcinoma.